反応式
[CH3:1][O:2][C:3]([C@@H:5]1[CH2:18][C@H:17](O)[C:16](=[O:20])[C@H:15]2[C@@:6]1([CH3:28])[CH2:7][CH2:8][C@H:9]1[C@:14]2([CH3:21])[CH2:13][C@@H:12]([C:22]2[CH:26]=[CH:25][O:24][CH:23]=2)[O:11][C:10]1=[O:27])=[O:4].C1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1.C(Br)(Br)[Br:49]>C(Cl)Cl>[CH3:1][O:2][C:3]([C@@H:5]1[CH2:18][C@@H:17]([Br:49])[C:16](=[O:20])[C@H:15]2[C@@:6]1([CH3:28])[CH2:7][CH2:8][C@H:9]1[C@:14]2([CH3:21])[CH2:13][C@@H:12]([C:22]2[CH:26]=[CH:25][O:24][CH:23]=2)[O:11][C:10]1=[O:27])=[O:4]参加物
反応物 3
生成物 1
試薬・触媒・溶媒 1
実験手順
A mixture of salvinorin B (8a) (0.15 g, 0.38 mmol), triphenylphosphine (0.21 g, 0.80 mmol), and bromoform (0.15 g, 0.45 mmol) in CH2Cl2 (30 mL) was stirred at room temperature overnight. TLC indicated that starting material was still present after 16 h, thus additional triphenylphosphine (0.11 g, 0.42 mmol) and bromoform (0.07 g, 0.21 mmol) were added and the mixture was stirred for an additional 3 h. The solvent was removed under reduced pressure affording a crude solid. The oil was purified by column chromatography (eluent: 30% EtOAc/n-hexanes) to afford 0.10 g (59%) of 36 as a white solid, mp 170-173° C. (EtOAc/n-hexanes); 1H NMR (CDCl3): δ 1.15 (3H, s); 1.48 (3H, s); 1.60 (3H, m); 1.81 (1H, dd, J=2.7, 9.9); 1.95 (1H, dd, J=13.2, 26.1); 2.1 (2H, m); 2.27 (1H, s); 2.47 (1H, dd, J=4.8, 13.2); 2.66 (1H, m); 2.80 (1H, dd, J=3.3, 13.2); 3.70 (3H, s); 3.89 (2H, d, J=2.4); 4.45 (1H, m); 5.55 (1H, dd, J=4.8, 11.7); 6.38 (1H, dd, J=0.9, 1.5); 7.4 (2H, m).
後処理
- waitwas still present after 16 h
- stirringthe mixture was stirred for an additional 3 h
- customThe solvent was removed under reduced pressure
- customaffording a crude solid
- customThe oil was purified by column chromatography (eluent: 30% EtOAc/n-hexanes)
出典と根拠
- ORDレコード
- ord-f9487c4143a64edc9e1870c4f003f434
- 出典データセット
- uspto-grants-2010_06
- 特許番号
- US07728001B2
関連ノート
読み込み中…